Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?
J Clin Oncol
.
2017 Jun 1;35(16):1858-1859.
doi: 10.1200/JCO.2016.71.6506.
Epub 2017 Mar 6.
Authors
Sebastiano Buti
1
,
Melissa Bersanelli
1
Affiliation
1
Sebastiano Buti and Melissa Bersanelli, University Hospital of Parma, Parma, Italy.
PMID:
28549228
DOI:
10.1200/JCO.2016.71.6506
No abstract available
Publication types
Letter
Comment
MeSH terms
Anilides
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms*
Pyridines
Sunitinib
Substances
Anilides
Pyridines
cabozantinib
Sunitinib